4.6 Article

A General Palladium-Catalyzed Sonogashira Coupling of Aryl and Heteroaryl Tosylates

期刊

CHEMISTRY-A EUROPEAN JOURNAL
卷 16, 期 33, 页码 9986-9989

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.201001524

关键词

alkynes; aryl tosylates; cross-coupling; palladium; Sonogashira coupling

资金

  1. European community

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis

Nis Halland, Friedemann Schmidt, Tilo Weiss, Ziyu Li, Jorg Czech, Joachim Saas, Danping Ding-Pfennigdorff, Matthias K. Dreyer, Carsten Strubing, Marc Nazare

Summary: A highly selective SGK1 inhibitor with optimized safety and pharmacokinetic profile for oral dosing has been identified as a potential disease-modifying agent for osteoarthritis.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast Cancer

Huayi Li, Lorenzo Prever, Myriam Y. Hsu, Wen-Ting Lo, Jean Piero Margaria, Maria Chiara De Santis, Cristina Zanini, Marco Forni, Francesco Novelli, Salvatore Pece, Pier Paolo Di Fiore, Paolo Ettore Porporato, Miriam Martini, Hassane Belabed, Marc Nazare, Volker Haucke, Federico Gulluni, Emilio Hirsch

Summary: Breast cancer is a common and deadly cancer in women. Overexpression of PI3KC2 alpha is correlated with high tumor grade and increased distant metastatic events in breast cancer patients. Mechanistically, PI3KC2 alpha synthesis of PI(3,4)P2 at focal adhesions leads to instability, and promotes migration, invasion, and metastasis of breast cancer cells.

ADVANCED SCIENCE (2022)

Article Chemistry, Medicinal

Compound Interaction Screen on a Photoactivatable Cellulose Membrane (CISCM) Identifies Drug Targets

F. Teresa Melder, Peter Lindemann, Alexander Welle, Vanessa Trouillet, Stefan Heissler, Marc Nazare, Matthias Selbach

Summary: This study presents a novel method for drug interaction screening on cellulose membranes and successfully applies it to the identification of multiple drug targets. The method reliably identifies known targets of natural products in a short period of time, providing an efficient means for drug development.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors

Edgar Specker, Susann Matthes, Radoslaw Wesolowski, Anja Schuetz, Maik Grohmann, Natalia Alenina, Dirk Pleimes, Keven Mallow, Martin Neuenschwander, Angelina Gogolin, Marie Weise, Jochen Pfeifer, Nandor Ziebart, Udo Heinemann, Jens Peter von Kries, Marc Nazare, Michael Bader

Summary: Tryptophan hydroxylases are crucial in the synthesis of serotonin, a neurotransmitter with important functions in the central nervous system. Dysregulation of peripheral serotonin levels has been linked to metabolic, inflammatory, and fibrotic diseases. This study presents a novel class of potent inhibitors for tryptophan hydroxylases that efficiently reduce peripheral serotonin levels without affecting serotonin levels in the brain.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α

Wen-Ting Lo, Hassane Belabed, Murat Kuecuekdisli, Juliane Metag, Yvette Roske, Polina Prokofeva, Yohei Ohashi, Andre Horatscheck, Davide Cirillo, Michael Krauss, Christopher Schmied, Martin Neuenschwander, Jens Peter von Kries, Guillaume Medard, Bernhard Kuster, Olga Perisic, Roger L. Williams, Oliver Daumke, Bernard Payrastre, Sonia Severin, Marc Nazare, Volker Haucke

Summary: In this study, we developed a novel PI3KC2 alpha catalytic activity inhibitor PITCOIN, which exhibits strong selectivity towards PI3KC2 alpha due to its unique mode of interaction with the ATP-binding site of the enzyme. It was demonstrated that PITCOINs can inhibit the PI3KC2 alpha-mediated synthesis of phosphatidylinositol 3-phosphates, impairing endocytic membrane dynamics and platelet-dependent thrombus formation.

NATURE CHEMICAL BIOLOGY (2023)

Article Multidisciplinary Sciences

Small molecule inhibiting microglial nitric oxide release could become a potential treatment for neuroinflammation

Philipp Jordan, Amanda Costa, Edgar Specker, Oliver Popp, Andrea Volkamer, Regina Piske, Tessa Obrusnik, Sabrina Kleissle, Kevin Stuke, Andre Rex, Martin Neuenschwander, Jens Peter von Kries, Marc Nazare, Phillip Mertins, Helmut Kettenmann, Susanne A. Wolf

Summary: Microglia, as the immune effector cells of the CNS, respond to pathologic events by releasing nitric oxide (NO). A compound called C1 was found to significantly reduce NO release in a dose-dependent manner, with a low IC50 (252 nM), and no toxic effects in vitro or in vivo. Target finding strategies, such as in silico modelling and mass spectroscopy, suggest a direct interaction between C1 and nitric oxide synthase, making C1 a promising candidate for specific intra-cellular interaction with the NO producing machinery.

PLOS ONE (2023)

Letter Hematology

SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells

Yannis Hara, Viktor T. Lemgart, Nis Halland, Kiana Mahdaviani, Jean-Antoine Ribeil, Samuel Lessard, Alexandra Hicks, David R. Light

BLOOD ADVANCES (2023)

Review Pharmacology & Pharmacy

Isoform-selective targeting of PI3K: time to consider new opportunities?

Davide Cirillo, Marta Diceglie, Marc Nazare

Summary: Phosphoinositide-3-kinases (PI3Ks) play a central role in various cellular signaling pathways and are potential targets for pharmacological treatment of diseases such as cancer, thrombosis, and pulmonary diseases. Isoform-selective inhibitors have been developed and approved, but challenges regarding drug tolerance have been observed. Therefore, additional approaches are needed, including targeting underexplored PI3K class II isoforms, to enhance the clinical benefits of specific treatment options. This review highlights recent discoveries in isoform-selective inhibitors, with a focus on PI3K class II isoforms, and emphasizes the importance of developing a broader arsenal of pharmacological tools.

TRENDS IN PHARMACOLOGICAL SCIENCES (2023)

Article Medicine, Research & Experimental

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod

Ludger Starke, Jason M. Millward, Christian Prinz, Fatima Sherazi, Helmar Waiczies, Christoph Lippert, Marc Nazare, Friedemann Paul, Thoralf Niendorf, Sonia Waiczies

Summary: The study demonstrates that siponimod can be imaged non-invasively using 19F UTE MRI, laying the foundation for further preclinical and clinical investigations. This technique provides an accurate understanding of the distribution of CNS-acting drugs in individual patients, which can contribute to personalized therapy.

THERANOSTICS (2023)

Meeting Abstract Oncology

Novel tetrazolopyridazine based MACC1 transcriptional inhibitors as promising anti-metastatic therapy

Paul Curtis Schope, Shixian Yan, Dennis Kobelt, Joe Lewis, Kerstin Putzker, Ulrike Uhrig, Edgar Specker, Jens Peter von Kries, Mathias Dahlmann, Hector E. Sanchez-Ibarra, Anke Unger, Mia-Lisa Zischinsky, Bert Klebl, Peter Lindemann, Wolfgang Walther, Marc Nazare, Ulrike Stein

CANCER RESEARCH (2023)

Article Chemistry, Medicinal

Probing Factor Xa Protein-Ligand Interactions: Accurate Free Energy Calculations and Experimental Validations of Two Series of High-Affinity Ligands

Maria Isabel Fernandez-Bachiller, Songhwan Hwang, Maria Elena Schembri, Peter Lindemann, Monica Guberman, Svenja Herziger, Edgar Specker, Hans Matter, David W. Will, Jorg Czech, Michael Wagner, Armin Bauer, Herman Schreuder, Kurt Ritter, Matthias Urmann, Volkmar Wehner, Han Sun, Marc Nazare

Summary: The study examined two series of factor Xa ligands through experimental and computational approaches, identifying new ligands with higher affinity and demonstrating the terminal alkyne moiety as a suitable non-classical bioisosteric replacement for higher halogen-pi aryl interactions.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Clinical Neurology

An LPAR5-antagonist that reduces nociception and increases pruriception

Jacqueline Langedijk, Erika Ivanna Araya, Amanda Ribeiro Barroso, Dagmar Tolenaars, Marc Nazare, Hassane Belabed, Jens Schoene, Juliana Geremias Chichorro, Ronald Oude Elferink

Summary: This study investigates the effects of the LPAR5 antagonist cpd3 on pain and itch signaling. The results show that cpd3 can reduce nociceptive behavior but induces scratching in mice. In vitro experiments reveal that cpd3 can activate TRPA1 to inhibit intracellular calcium release. However, this effect is not observed in TRPA1-deficient mice. These findings highlight the importance of screening antinociceptive drugs for their activity with pruriceptors.

FRONTIERS IN PAIN RESEARCH (2022)

Article Chemistry, Multidisciplinary

Reverse Design toward Optimized Labeled Chemical Probes - Examples from the Endocannabinoid System

Monica Guberman, Miroslav Kosar, Anahid Omran, Erick M. Carreira, Marc Nazare, Uwe Grether

Summary: Labeled chemical probes are crucial for the development and commercialization of drugs. They play a significant role in various research phases and provide valuable tools for specific application needs. The reverse-design approach enables the generation of high-quality probes based on previously optimized small molecules, fostering collaborations between academia and industry.

CHIMIA (2022)

Article Biochemistry & Molecular Biology

Identification of the Allosteric Binding Site for Thiazolopyrimidine on the Lectin Langerin

Hengxi Zhang, Carlos Modenutti, Yelha Phani Kumar Nekkanti, Maxime Denis, Iris A. Bermejo, Jonathan Lefebre, Kateryna Che, Dongyoon Kim, Marten Kagelmacher, Dennis Kurzbach, Marc Nazare, Christoph Rademacher

Summary: This study investigated the exact binding site of human and murine homologues of Langerin using structural comparison and molecular dynamics simulations. It was found that the nonconserved short loops exhibited a high degree of conformational flexibility between the two homologues. Sequence analysis and mutational studies identified a pair of residues essential for recognizing thiazolopyrimidines. By utilizing solvent paramagnetic relaxation enhancement NMR studies and a series of peptides, the allosteric binding site for these aromatic heterocycles was determined to be the cleft between the short and long loops.

ACS CHEMICAL BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe

Thais Gazzi, Benjamin Brennecke, Kenneth Atz, Claudia Korn, David Sykes, Gabriel Forn-Cuni, Patrick Pfaff, Roman C. Sarott, Matthias Westphal, Yelena Mostinski, Leonard Mach, Malgorzata Wasinska-Kalwa, Marie Weise, Bradley L. Hoare, Tamara Miljus, Maira Mexi, Nicolas Roth, Eline J. Koers, Wolfgang Guba, Andre Alker, Arne C. Rufer, Eric A. Kusznir, Sylwia Huber, Catarina Raposo, Elisabeth A. Zirwes, Anja Osterwald, Anto Pavlovic, Svenja Moes, Jennifer Beck, Matthias Nettekoven, Irene Benito-Cuesta, Teresa Grande, Faye Drawnel, Gabriella Widmer, Daniela Holzer, Tom van der Wel, Harpreet Mandhair, Michael Honer, Jurgen Fingerle, Joerg Scheffel, Johannes Broichhagen, Klaus Gawrisch, Julian Romero, Cecilia J. Hillard, Zoltan V. Varga, Mario van der Stelt, Pal Pacher, Jurg Gertsch, Christoph Ullmer, Peter J. McCormick, Sergio Oddi, Herman P. Spaink, Mauro Maccarrone, Dmitry B. Veprintsev, Erick M. Carreira, Uwe Grether, Marc Nazare

Summary: This study reports the development of a novel fluorescent CB2R agonist probe that can detect CB2R in living cells and zebrafish larvae. These findings contribute to the clinical translatability of CB2R-based drugs.

CHEMICAL SCIENCE (2022)

暂无数据